This site is intended for health professionals only

Lundbeck data updated


H. Lundbeck A/S (Lundbeck) today publishes the total number of voting rights and total share capital in the company cf. section 6 of the Executive Order on Issuers’ Disclosure Obligations:

  • Total Number of Voting Rights: 196,135,918 (previously: 196,116,634)
  • Total Share Capital: DKK 980,679,590 (previously: DKK 980,583,170

As communicated on 16 May 2011 (release no 438) and also in connection with the company’s results for the first nine months of 2010 (3 November 2010), Lundbeck operates with Long-Term Incentive schemes (LTI) for the executive management and key employees in Denmark and abroad. To fund the programme Lundbeck has bought the necessary Lundbeck shares in full compliance with the existing NASDAQ OMX Copenhagen rules regarding trading with treasury shares and Lundbeck’s internal rules.

The number of treasury shares included in the schemes currently amounts to less than 0.1% of the share capital per scheme. The purchases to fund the programme will be made as late as possible in order to mirror the final number needed. For the 2012 and 2013 transfer of shares, the corresponding figures are 89,740 and 94,953 shares, which is equal to approximately DKK 12m (€1.6m) and DKK 13m (€1.7m) at the present share price.

The schemes are charged continuously to the P&L and the purchase of treasury shares will have no effect on the P&L.

Financial guidance

The content of this release will have no influence on the Lundbeck Group’s financial guidance for 2011 which was provided on 24 February 2011 in connection with the release of the financial results for 2010.


Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine